Related Experiment Video
Updated: May 4, 2026
06:49
A Standardized Approach to Extra-Oral and Intra-Oral Digital Photography
Published on: July 22, 2022
11.0K
Drug interactions in general dental practice--considerations for the dental practitioner
B E S Dawoud1, A Roberts2, J M Yates3
1Dental Foundation Trainee, 228-230 Ash Dental Practice, Manchester, Eccles, M30 0PF.
British Dental Journal
|January 14, 2014
Summary
General dental practitioners must be aware of potential drug-drug interactions. This article reviews common medications that may interact with those prescribed in dental practice, using NHS statistics.
Area of Science:
- Pharmacology
- Dental Practice
- Drug Interactions
Background:
- Drug-drug interactions (DDIs) pose a significant challenge in healthcare.
- General dental practitioners (GDPs) frequently prescribe medications.
- Understanding potential DDIs is crucial for patient safety in dental settings.
Purpose of the Study:
- To explore the complexities of pharmacological drug-drug interactions within general dental practice.
- To identify common medications for prevalent medical conditions that may interact with drugs prescribed by GDPs.
Main Methods:
- Analysis of published National Health Service (NHS) statistics.
- Review of frequently prescribed dental medications.
- Identification of potential interaction profiles between common systemic and dental drugs.
Main Results:
- Specific examples of high-risk drug combinations relevant to dental prescribing will be presented.
- The prevalence of certain medical conditions and their associated medications in patients seeking dental care will be highlighted.
- Potential interactions impacting the efficacy or safety of dental treatments will be detailed.
Conclusions:
- Enhanced awareness and knowledge of DDIs are essential for GDPs.
- Proactive management of potential drug interactions can improve patient outcomes and prevent adverse events.
- Further education and resources are needed to support GDPs in navigating complex pharmacological interactions.
More Related Videos
Related Concept Videos
01:25Pharmacokinetics: Drug–Drug Interactions
813
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
813
01:30Drug toxicity: Drug–Drug Interaction
423
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
423
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
695
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
695
01:24Dosage Regimen: Individualization
398
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
398
01:24Drug Toxicity: Risk factors
229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
01:15Drug Dosing: Geriatric Patients
395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395